In situ nasal gel drug delivery: A novel approach for brain targeting through the mucosal membrane
Source abstract
Abstract
Recently, sustained and controlled drug delivery has become the demand, and research has been undertaken in achieving much better drug product effectiveness, reliability and safety. The in situ polymeric system has gained much attention, to develop a controlled release system. It has been used as a vehicle for local and systemic drug delivery. Nowadays, it has created much interest, because of its characteristics of high vascularization, high permeability, rapid onset of action, low enzymatic degradation, and avoidance of hepatic first pass metabolism. The main aim of this review is to provide knowledge of different mechanisms of nasal absorption and approaches for nasal drug delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
,
References (89)
Show source-provided references
1. 10.1016/j.ejps.2010.05.00310.1016/j.ejps.2010.05.003 ↗
2. 10.2174/13816121079116410810.2174/138161210791164108 ↗
3. 10.1248/cpb.55.171310.1248/cpb.55.1713 ↗
4. 10.1208/s12249-010-9477-x10.1208/s12249-010-9477-x ↗
5. Bird, S, Derry, S, Moore, RA. 2014. Zolmitriptan for acute migraine attacks in adults. Cochrane Database Syst Rev. 5:CD008616.
6. 10.1016/S0142-9612(00)00107-110.1016/S0142-9612(00)00107-1 ↗
7. 10.1007/BF0299397110.1007/BF02993971 ↗
8. 10.1016/j.ijpharm.2008.08.04210.1016/j.ijpharm.2008.08.042 ↗
9. 10.1016/S0928-0987(97)00074-210.1016/S0928-0987(97)00074-2 ↗
10. 10.3109/1061186X.2014.95066410.3109/1061186X.2014.950664 ↗
11. 10.3109/0363904090326437110.3109/03639040903264371 ↗
12. 10.1016/S0378-5173(03)00259-X10.1016/S0378-5173(03)00259-X ↗
13. Doring, K, Best, C, Birklein, F, Kramer, HH. 2014. Zolmitriptan inhibits neurogenic inflammation and pain during electrical stimulation in human skin. Eur J Pain.
14. 10.1111/j.2042-7158.1992.tb05462.x10.1111/j.2042-7158.1992.tb05462.x ↗
15. 10.1016/j.ejps.2013.11.01610.1016/j.ejps.2013.11.016 ↗
16. 10.3109/21691401.2014.91671510.3109/21691401.2014.916715 ↗
17. 10.2174/2210304x1120204000510.2174/2210304x11202040005 ↗
18. 10.1517/17425247.2014.89101410.1517/17425247.2014.891014 ↗
19. 10.2174/2210303111303666001510.2174/22103031113036660015 ↗
20. 10.2174/221030310399913121111041410.2174/2210303103999131211110414 ↗
21. 10.2174/2210304x1120204000310.2174/2210304x11202040003 ↗
22. 10.1615/CritRevTherDrugCarrierSyst.201401110410.1615/CritRevTherDrugCarrierSyst.2014011104 ↗
23. 10.1615/CritRevTherDrugCarrierSyst.201401012210.1615/CritRevTherDrugCarrierSyst.2014010122 ↗
24. Garg, T, Rath, G, Goyal, AK. 2014c. Biomaterials-based nanofiber scaffold: targeted and controlled carrier for cell and drug delivery. J Drug Target. 1–20.
25. Garg, T, Rath, G, Goyal, AK. 2014d. Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv.
26. Garg, T, Singh, O, Arora, S, Murthy, R. 2011a. Dendrimer—A novel scaffold for drug delivery. Int J Pharm Sci Rev Res. 7:211–220.
27. Garg, T, Singh, O, Arora, S, Murthy, R. 2011b. Patented microencapsulation techniques and its application. J Pharm Res. 4:2097–2102.
28. 10.1615/CritRevTherDrugCarrierSyst.v29.i1.1010.1615/CritRevTherDrugCarrierSyst.v29.i1.10 ↗
29. 10.1615/CritRevTherDrugCarrierSyst.201300725910.1615/CritRevTherDrugCarrierSyst.2013007259 ↗
30. 10.1016/j.ijpharm.2005.09.01310.1016/j.ijpharm.2005.09.013 ↗
31. 10.1007/978-3-662-45775-7_410.1007/978-3-662-45775-7_4 ↗
32. Goyal, G, Garg, T, Malik, B, Chauhan, G, Rath, G, Goyal, AK. 2013b. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv.
33. 10.1615/CritRevTherDrugCarrierSyst.201400811710.1615/CritRevTherDrugCarrierSyst.2014008117 ↗
34. 10.1615/CritRevTherDrugCarrierSyst.201401012310.1615/CritRevTherDrugCarrierSyst.2014010123 ↗
35. 10.3109/03639045.2011.60819110.3109/03639045.2011.608191 ↗
36. Hoffler, D, Nebe, K, Wiethoff, EO. 1972. [Studies on the absorption of the combined administration of erythromycin and bromohexine hydrochloride]. Arzneimittelforschung. 22:97–100.
37. 10.1166/jbt.2014.121410.1166/jbt.2014.1214 ↗
38. 10.1016/j.parint.2014.12.00610.1016/j.parint.2014.12.006 ↗
39. 10.1016/S0928-0987(00)00087-710.1016/S0928-0987(00)00087-7 ↗
40. 10.1016/S0168-3659(02)00363-210.1016/S0168-3659(02)00363-2 ↗
41. 10.1002/jps.2071810.1002/jps.20718 ↗
42. 10.3109/10717544.2014.92876010.3109/10717544.2014.928760 ↗
43. 10.3109/10717544.2014.93553110.3109/10717544.2014.935531 ↗
44. Joshi, D, Garg, T, Goyal, AK, Rath, G. 2014b. Development and characterization of novel medicated nanofibers against periodontitis. Curr Drug Deliv.
45. 10.3109/21691401.2014.98430310.3109/21691401.2014.984303 ↗
46. 10.1152/ajpgi.00242.201310.1152/ajpgi.00242.2013 ↗
47. 10.2174/2210303111303666001810.2174/22103031113036660018 ↗
48. 10.3109/21691401.2014.98430210.3109/21691401.2014.984302 ↗
49. 10.1615/CritRevTherDrugCarrierSyst.201400828510.1615/CritRevTherDrugCarrierSyst.2014008285 ↗
50. Kaur, M, Malik, B, Garg, T, Rath, G, Goyal, AK. 2014c. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv.
51. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
52. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
53. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
54. Kaur, P, Garg, T, Vaidya, B, Prakash, A, Rath, G, Goyal, AK. 2014g. Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment. J Drug Target. 1–12.
55. 10.3109/21691401.2014.98430210.3109/21691401.2014.984302 ↗
56. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
57. 10.1615/CritRevTherDrugCarrierSyst.201401052710.1615/CritRevTherDrugCarrierSyst.2014010527 ↗
58. Kaur, V, Garg, T, Rath, G, Goyal, AK. 2014k. Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target. 1–12.
59. 10.1016/S0378-5173(99)00026-510.1016/S0378-5173(99)00026-5 ↗
60. 10.2174/15672010677773101910.2174/156720106777731019 ↗
61. 10.1208/pt07036710.1208/pt070367 ↗
62. Malik, R, Garg, T, Goyal, AK, Rath, G. 2014. Polymeric nanofibers: targeted gastro-retentive drug delivery systems. J Drug Target. 1–16.
63. 10.1016/j.ijpharm.2003.11.02810.1016/j.ijpharm.2003.11.028 ↗
64. 10.3109/10717544.2014.93553210.3109/10717544.2014.935532 ↗
65. 10.3109/21691401.2014.92400710.3109/21691401.2014.924007 ↗
66. Modgill, V, Garg, T, Goyal, AK, Rath, G. 2014b. Transmucosal Delivery of Linagliptin for the Treatment of Type- 2 Diabetes Mellitus by Ultra-Thin Nanofibers. Curr Drug Deliv.
67. 10.3109/21691401.2014.92787910.3109/21691401.2014.927879 ↗
68. 10.3109/21691401.2014.96619510.3109/21691401.2014.966195 ↗
69. 10.1126/science.813483510.1126/science.8134835 ↗
70. 10.1016/S0142-9612(00)00020-X10.1016/S0142-9612(00)00020-X ↗
71. 10.1016/S0169-409X(01)00203-410.1016/S0169-409X(01)00203-4 ↗
72. 10.3109/10717544.2014.94501810.3109/10717544.2014.945018 ↗
73. 10.3109/10717544.2014.94501810.3109/10717544.2014.945018 ↗
74. 10.1016/S0169-409X(97)00121-X10.1016/S0169-409X(97)00121-X ↗
75. 10.1007/BF0319228510.1007/BF03192285 ↗
76. Sharma, A, Garg, T, Aman, A, Panchal, K, Sharma, R, Kumar, S, Markandeywar, T. 2014a. Nanogel-an advanced drug delivery tool: current and future. Artif Cells Nanomed Biotechnol. 1–13.
77. Sharma, R, Garg, T, Goyal, AK, Rath, G. 2014b. Development, optimization and evaluation of polymeric electrospun nanofiber: A tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol. 1–8.
78. 10.1615/CritRevTherDrugCarrierSyst.201400819310.1615/CritRevTherDrugCarrierSyst.2014008193 ↗
79. Singh, B, Garg, T, Goyal, AK, Rath, G. 2014a. Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol. 1–10.
80. Singh, H, Sharma, R, Joshi, M, Garg, T, Goyal, AK, Rath, G. 2014b. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol.
81. Singh, K, Arora, N, Garg, T. 2012. RFID: a trustable security tool in pharmaceutical industry. Am J Pharm Tech Res. 2:113–127.
82. Singh, O, Garg, T, Rath, G, Goyal, AK. 2014c. Microbicides for the treatment of sexually transmitted HIV infections. J Pharm. 1–18.
83. 10.1208/s12249-013-9921-910.1208/s12249-013-9921-9 ↗
84. 10.1016/S0378-5173(98)00367-610.1016/S0378-5173(98)00367-6 ↗
85. 10.3109/1061186X.2012.71923010.3109/1061186X.2012.719230 ↗
86. 10.1016/j.ejpb.2008.07.00510.1016/j.ejpb.2008.07.005 ↗
87. 10.1016/S0168-3659(02)00175-X10.1016/S0168-3659(02)00175-X ↗
88. 10.1016/j.jacc.2013.11.04210.1016/j.jacc.2013.11.042 ↗
89. 10.1186/1472-6882-14-35710.1186/1472-6882-14-357 ↗